PTAB Begins IPR Review of Two Sanofi Patents

Drug Industry Daily
A A
The PTO’s Patent Trials and Appeals Board launched an inter partes review of two patents for Sanofi’s Lantus insulin glargine injection following a challenge from Mylan.

To View This Article:

Login

Subscribe To Drug Industry Daily